Skip to content

Clinical trials

Phase 1 Scleroderma, Systemic trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 1 Status: Unknown status Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PersonGen BioTherapeutics (Suzhou) Co., Ltd.1
Radboud University Medical Center1
RenJi Hospital1
Second Xiangya Hospital of Central South University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic4
Lupus Erythematosus, Systemic2
Myositis2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Arthritis, Rheumatoid1
Fibrosis1
Liver Cirrhosis, Biliary1
Purpura, Thrombocytopenic, Idiopathic1
Sjogren's Syndrome1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.